PETER MARKS ADMITS THE FDA WAS SURPRISED BY SOME EFFICACY AND DURABILITY ISSUES IN GENE THERAPY - BUT THINKS THESE WILL BE JUST A 'BUMP IN THE ROAD'. • Source: Danny Al-Faruque
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
